These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9879670

  • 1. Enzymatic properties of overexpressed human hexokinase fragments.
    Bianchi M, Serafini G, Bartolucci E, Giammarini C, Magnani M.
    Mol Cell Biochem; 1998 Dec; 189(1-2):185-93. PubMed ID: 9879670
    [Abstract] [Full Text] [Related]

  • 2. A recombinant human 'mini'-hexokinase is catalytically active and regulated by hexose 6-phosphates.
    Magnani M, Bianchi M, Casabianca A, Stocchi V, Daniele A, Altruda F, Ferrone M, Silengo L.
    Biochem J; 1992 Jul 01; 285 ( Pt 1)(Pt 1):193-9. PubMed ID: 1637300
    [Abstract] [Full Text] [Related]

  • 3. Binding of nucleoside triphosphates, inorganic phosphate, and other polyanionic ligands to the N-terminal region of rat brain hexokinase: relationship to regulation of hexokinase activity by antagonistic interactions between glucose 6-phosphate and inorganic phosphate.
    White TK, Wilson JE.
    Arch Biochem Biophys; 1990 Feb 15; 277(1):26-34. PubMed ID: 2306121
    [Abstract] [Full Text] [Related]

  • 4. Isolation and characterization of the discrete N- and C-terminal halves of rat brain hexokinase: retention of full catalytic activity in the isolated C-terminal half.
    White TK, Wilson JE.
    Arch Biochem Biophys; 1989 Nov 01; 274(2):375-93. PubMed ID: 2802617
    [Abstract] [Full Text] [Related]

  • 5. Residues putatively involved in binding of ATP and glucose 6-phosphate to a mammalian hexokinase: site-directed mutation at analogous positions in the N- and C-terminal halves of the type I isozyme.
    Baijal M, Wilson JE.
    Arch Biochem Biophys; 1995 Aug 20; 321(2):413-20. PubMed ID: 7646067
    [Abstract] [Full Text] [Related]

  • 6. Hexokinase in astrocytes: kinetic and regulatory properties.
    Lai JC, Behar KL, Liang BB, Hertz L.
    Metab Brain Dis; 1999 Jun 20; 14(2):125-33. PubMed ID: 10488914
    [Abstract] [Full Text] [Related]

  • 7. Kinetic and regulatory properties of HK I(+), a modified form of the type I isozyme of mammalian hexokinase in which interactions between the N- and C-terminal halves have been disrupted.
    Hashimoto M, Wilson JE.
    Arch Biochem Biophys; 2002 Mar 01; 399(1):109-15. PubMed ID: 11883910
    [Abstract] [Full Text] [Related]

  • 8. Effect of ligand binding on the tryptic digestion pattern of rat brain hexokinase: relationship of ligand-induced conformational changes to catalytic and regulatory functions.
    Smith AD, Wilson JE.
    Arch Biochem Biophys; 1991 Nov 15; 291(1):59-68. PubMed ID: 1929435
    [Abstract] [Full Text] [Related]

  • 9. Mitochondrial hexokinase from differentiated and undifferentiated HT29 colon cancer cells: effect of some metabolites on the bound/soluble equilibrium.
    Gauthier T, Denis-Pouxviel C, Murat JC.
    Int J Biochem; 1990 Nov 15; 22(4):419-23. PubMed ID: 2338166
    [Abstract] [Full Text] [Related]

  • 10. The interaction of phosphorylated sugars with human hexokinase I.
    Magnani M, Stocchi V, Serafini G, Chiarantini L.
    Biochim Biophys Acta; 1988 Jun 13; 954(3):336-42. PubMed ID: 3259434
    [Abstract] [Full Text] [Related]

  • 11. One-step purification of a fully active hexahistidine-tagged human hexokinase type I overexpressed in Escherichia coli.
    Palma F, Longhi S, Agostini D, Stocchi V.
    Protein Expr Purif; 2001 Jun 13; 22(1):38-44. PubMed ID: 11388797
    [Abstract] [Full Text] [Related]

  • 12. Complementarity in the regulation of phosphoglucomutase, phosphofructokinase and hexokinase; the role of glucose 1,6-bisphosphate.
    Beitner R, Haberman S, Livni L.
    Biochim Biophys Acta; 1975 Aug 26; 397(2):355-69. PubMed ID: 125609
    [Abstract] [Full Text] [Related]

  • 13. Enzymatic properties of the N- and C-terminal halves of human hexokinase II.
    Ahn KJ, Kim J, Yun M, Park JH, Lee JD.
    BMB Rep; 2009 Jun 30; 42(6):350-5. PubMed ID: 19558793
    [Abstract] [Full Text] [Related]

  • 14. High-level expression and purification of a human "mini"-hexokinase.
    Bianchi M, Serafini G, Corsi D, Magnani M.
    Protein Expr Purif; 1996 Feb 30; 7(1):58-66. PubMed ID: 9172784
    [Abstract] [Full Text] [Related]

  • 15. Functional organization of mammalian hexokinases: characterization of chimeric hexokinases constructed from the N- and C-terminal domains of the rat type I and type II isozymes.
    Tsai HJ, Wilson JE.
    Arch Biochem Biophys; 1995 Jan 10; 316(1):206-14. PubMed ID: 7840618
    [Abstract] [Full Text] [Related]

  • 16. Expression, purification, and characterization of a recombinant erythroid-specific hexokinase isozyme.
    Bianchi M, Serafini G, Bartolucci E, Palma F, Magnani M.
    Blood Cells Mol Dis; 1998 Dec 10; 24(4):401-11. PubMed ID: 9851893
    [Abstract] [Full Text] [Related]

  • 17. Effect of inorganic phosphate on the reverse reaction of bovine brain hexokinase.
    Solheim LP, Fromm HJ.
    Biochemistry; 1983 Apr 26; 22(9):2234-9. PubMed ID: 6860661
    [Abstract] [Full Text] [Related]

  • 18. Mitochondrial hexokinase in brain: coexistence of forms differing in sensitivity to solubilization by glucose-6-phosphate on the same mitochondria.
    Kabir F, Wilson JE.
    Arch Biochem Biophys; 1994 May 01; 310(2):410-6. PubMed ID: 8179326
    [Abstract] [Full Text] [Related]

  • 19. Comparison of type I hexokinases from pig heart and kinetic evaluation of the effects of inhibitors.
    Vowles DT, Easterby JS.
    Biochim Biophys Acta; 1979 Feb 09; 566(2):283-95. PubMed ID: 420859
    [Abstract] [Full Text] [Related]

  • 20. Functional consequences of mutation of highly conserved serine residues, found at equivalent positions in the N- and C-terminal domains of mammalian hexokinases.
    Baijal M, Wilson JE.
    Arch Biochem Biophys; 1992 Oct 09; 298(1):271-8. PubMed ID: 1524437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.